Trial Outcomes & Findings for The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery (NCT NCT02580188)

NCT ID: NCT02580188

Last Updated: 2019-03-13

Results Overview

Intra-abdominal pressure was maintained at 12 mmHg during pneumoperitoneum(using the carbon dioxide gas insufflation) and the pressure alarm for IAP was set at \< 15 mmHg. Intra-abdominal pressure is measured in a separate machine connected to a carbon dioxide gas injection line.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

70 participants

Primary outcome timeframe

intraoperative, an averrage of 3 hour

Results posted on

2019-03-13

Participant Flow

Participant milestones

Participant milestones
Measure
Group M
Maintenance dose of 0.15-0.3 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of train of four count 1-2 (moderate block). At the end of surgery neostigmine 50 ㎍/kg with glycopyrrolate 10 ㎍/kg are administered IV for reversal of neuromuscular block.
Group D
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block). At the end of surgery, sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block sugammadex: Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).
Overall Study
STARTED
35
35
Overall Study
COMPLETED
32
32
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group M
n=35 Participants
Maintenance dose of 0.15-0.3 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of train of four count 1-2 (moderate block). At the end of surgery neostigmine 50 ㎍/kg with glycopyrrolate 10 ㎍/kg are administered IV for reversal of neuromuscular block.
Group D
n=35 Participants
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block). At the end of surgery, sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block sugammadex: Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).
Total
n=70 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
Age, Categorical
Between 18 and 65 years
21 Participants
n=39 Participants
24 Participants
n=41 Participants
45 Participants
n=35 Participants
Age, Categorical
>=65 years
14 Participants
n=39 Participants
11 Participants
n=41 Participants
25 Participants
n=35 Participants
Sex: Female, Male
Female
14 Participants
n=39 Participants
15 Participants
n=41 Participants
29 Participants
n=35 Participants
Sex: Female, Male
Male
21 Participants
n=39 Participants
20 Participants
n=41 Participants
41 Participants
n=35 Participants

PRIMARY outcome

Timeframe: intraoperative, an averrage of 3 hour

Intra-abdominal pressure was maintained at 12 mmHg during pneumoperitoneum(using the carbon dioxide gas insufflation) and the pressure alarm for IAP was set at \< 15 mmHg. Intra-abdominal pressure is measured in a separate machine connected to a carbon dioxide gas injection line.

Outcome measures

Outcome measures
Measure
Moderate Block
n=32 Participants
Maintenance dose of 0.15-0.3 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of train of four count 1-2 (moderate block). At the end of surgery neostigmine 50 ㎍/kg with glycopyrrolate 10 ㎍/kg are administered IV for reversal of neuromuscular block.
Deep Block
n=32 Participants
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block). At the end of surgery, sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block sugammadex: Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).
Number of Participants With Increased Intra-abdominal Pressure (IAP) Alarm as > 15 mmHg
14 Participants
6 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 24hr after end of operation

Postoperative pain is controlled by IV patient controlled analgesia using fentanyl. If patient complain of severe pain (VNRS score of 7 or more), additional analgesics can be used according to the attending physician.

Outcome measures

Outcome measures
Measure
Moderate Block
n=32 Participants
Maintenance dose of 0.15-0.3 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of train of four count 1-2 (moderate block). At the end of surgery neostigmine 50 ㎍/kg with glycopyrrolate 10 ㎍/kg are administered IV for reversal of neuromuscular block.
Deep Block
n=32 Participants
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block). At the end of surgery, sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block sugammadex: Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).
Postoperative Pain is Evaluated by Verbal Numerical Rating Scale (VNRS, 0 = no Pain, 10 = the Severest Pain Imaginable)
4.5 score on a scale
Interval 1.0 to 7.0
4 score on a scale
Interval 0.0 to 8.0

OTHER_PRE_SPECIFIED outcome

Timeframe: 48hr after end of operation

Postoperative pain is controlled by IV patient controlled analgesia using fentanyl. If patient complain of severe pain (VNRS score of 7 or more), additional analgesics can be used according to the attending physician.

Outcome measures

Outcome measures
Measure
Moderate Block
n=32 Participants
Maintenance dose of 0.15-0.3 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of train of four count 1-2 (moderate block). At the end of surgery neostigmine 50 ㎍/kg with glycopyrrolate 10 ㎍/kg are administered IV for reversal of neuromuscular block.
Deep Block
n=32 Participants
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block). At the end of surgery, sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block sugammadex: Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium is continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).
Postoperative Pain is Evaluated by Verbal Numerical Rating Scale (VNRS, 0 = no Pain, 10 = the Severest Pain Imaginable)
3 score on a scale
Interval 0.0 to 8.0
2 score on a scale
Interval 0.0 to 7.0

Adverse Events

Group M

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group D

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Bon-wook Koo

SNUBH

Phone: +82-10-7227-1379

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place